logo
  • Home
  • Applications
    • Indications
  • Business
  • Technology
  • Investors
    • Investors Overview
    • Results and Presentations
    • Share Price Information
    • Regulatory News
    • Board & Governance
    • Key Corporate Documents
    • AIM Rule 26
    • Email Alerts
    • Investor Contacts
  • News
  • About Us
    • History
    • Board of Directors
    • Management Team
    • Scientific Advisory Panel
    • Values
    • Careers
  • Contact Us
  • Service

Month: January 2017

OBD announces Financial Results.

Press Release

by oxfordbiodynamics

OBD has achieved Investors in People standard accreditation.

by Aroul Ramadass

Oxford BioDynamics enters into pilot project with EpiFit to analyse the effect of fitness regimes using EpiSwitch™.

EpiFit agreement - Press release

by Aroul Ramadass

Capturing genomic relationships that matter.

by Aroul Ramadass

OBD to promote EpiSwitch™ technology at the 12th Annual Biomarker Congress.

annual_biomarkers_2017

by Aroul Ramadass

Terms of Use 
Site Map

Privacy Policy
Cookies Policy

Regulated and Licensed by Human Tissue Authority
License No. 12571

© 2002-2018 Oxford Biodynamics Plc

Privacy Preference Center

Privacy Preferences

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with this.OkRead more